drugset / Trial / NCT04600037
Pregabalin Treatment for Trigger Points
RandomizedParallel-groupSingle-blindOther
Summary
Myofascial pain syndrome (MPS) is a common problem in the general population. MPS should not be a local/peripheral painful syndrome and considered to be a syndrome of central sensitivity. We aimed to investigate the effect of pregabalin in patients with MPS in this study
Timeline
- Start
- 2014-04-26
- Primary completion
- 2014-07-26
- Completion
- 2015-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pregabalin | Small molecule | 150 mg | — |